Hematology and Blood Disorders

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Reach Us +1 (202) 780-3397

Perspective - Hematology and Blood Disorders (2023) Volume 6, Issue 4

Thrombocytopenia: An overview of low platelet count disorder

Blake Archer *

Department of Pediatric Hematology, Stanford University, United States

*Corresponding Author:
Blake Archer
Department of Pediatric Hematology, Stanford University, United States
E-mail: Blake33@stanford.edu

Received: 28-Feb-2024, Manuscript No. AAHBD-24-136388; Editor assigned: 01-Mar-2024, PreQC No AAHBD-24-136388 (PQ) Reviewed:14-Mar-2024, QC No. AAHBD-24-136388Revised:20-Mar-2024, Manuscript No. AAHBD-24-136388 (R); Published:27-Mar-2024, DOI:10.35841/aahbd-6.4.158

Citation: Archer B. Thrombocytopenia: An overview of low platelet count disorder. Hematol Blood Disord. 2024;6(4):158

Visit for more related articles at Hematology and Blood Disorders

Introduction

Thrombocytopenia is a medical condition characterized by an abnormally low level of platelets, also known as thrombocytes, in the blood. Platelets are crucial for blood clotting and wound healing, as they aggregate at the site of a blood vessel injury, forming a clot to stop bleeding. When platelet levels fall below the normal range (150,000 to 450,000 platelets per microliter of blood), it can lead to excessive bleeding and bruising. This article explores the causes, symptoms, diagnosis, and treatment of thrombocytopenia [1].

Thrombocytopenia can result from various factors, which can be broadly categorized into three groups: decreased platelet production, increased platelet destruction, and sequestration of platelets [2].

Decreased Platelet Production: This can occur due to bone marrow disorders, such as leukemia, myelodysplastic syndromes, and aplastic anemia. Other causes include viral infections (e.g., HIV, hepatitis C), chemotherapy, radiation therapy, and certain medications [3].

Increased Platelet Destruction: Conditions that cause increased destruction of platelets include immune thrombocytopenia (ITP), thrombotic thrombocytopenic purpura (TTP), and disseminated intravascular coagulation (DIC). Additionally, medications, autoimmune diseases, and infections can also lead to increased platelet destruction [4].

Sequestration: The spleen normally stores a portion of the body's platelets. An enlarged spleen (splenomegaly) due to liver disease, cancer, or other conditions can sequester too many platelets, reducing the number in circulation [5].

The symptoms of thrombocytopenia can vary depending on the severity of the condition. Common symptoms include: Easy or excessive bruising: Small red or purple spots (petechiae) on the skin, often on the lower legs. Prolonged bleeding from cuts: Increased bleeding after injury or surgery [6].

Spontaneous bleeding: Nosebleeds, bleeding gums, or blood in urine or stools. Heavy menstrual periods: For women, unusually heavy menstrual flow. Fatigue: Due to blood loss and anemia in severe cases [7].

Diagnosing thrombocytopenia involves a thorough medical history and physical examination, followed by laboratory tests to determine the underlying cause: Complete Blood Count (CBC): To measure platelet levels and assess other blood cell components. Blood Smear: To examine the appearance of platelets and other blood cells under a microscope. Bone Marrow Biopsy: To evaluate bone marrow function and rule out bone marrow disorders [8].

Treatment for thrombocytopenia depends on the underlying cause and the severity of the condition. Approaches may include: Observation: In mild cases without significant symptoms, monitoring platelet levels without immediate intervention. Medications: Corticosteroids or immunoglobulins for immune-mediated thrombocytopenia; medications to stimulate platelet production. Blood or Platelet Transfusions: In cases of severe bleeding or very low platelet counts [9].

Treating Underlying Conditions: Addressing infections, discontinuing causative medications, or treating underlying diseases like leukemia or liver disease. Surgery: Splenectomy (removal of the spleen) in cases of severe splenomegaly or refractory immune thrombocytopenia [10].

Conclusion

Thrombocytopenia is a condition with diverse etiologies and potential complications that can significantly impact a patient's quality of life. Early diagnosis and appropriate treatment are crucial to manage symptoms and prevent serious bleeding events. Ongoing research and advancements in medical science continue to improve our understanding and management of this condition, offering hope for better outcomes for those affected.

References

  1. Bignardi PR,. Acute kidney injury associated with dengue virus infection: a review. Brazilian J Nephrol. 2022;44:232-7.

    2. Indexed at, Google Scholar, Cross Ref

  2. Gauer RL, Braun MM. Thrombocytopenia. American family physician. 2012;85(6):612-22.

    3. Google Scholar

  3. Cuker A, Cines DB. Immune thrombocytopenia. Hematology 2010, the American Society of Hematology Education Program Book. 2010;2010(1):377-84.

    4. Indexed at, Google Scholar

  4. Chobanian AV, Hill M. National Heart, Lung, and Blood Institute Workshop on Sodium and Blood Pressure: a critical review of current scientific evidence. Hypertension. 2000;35(4):858-63.

    5. Indexed at, Google Scholar, Cross Ref

  5. Kistangari G, McCrae KR. Immune thrombocytopenia. Hematology/Oncology Clinics. 2013;27(3):495-520.

    6. Indexed at, Google Scholar

  6. Adewoye AH, Nolan VG, Ma Q. Hemostasis and thrombosis. Genetics. 2007;119:U13-7.

    7. Indexed at, Google Scholar

  7. Anemia H. Bibliography Current World Literature Vol 10 No 6 November 2003. Cur Opin in Hematol2003;10:469-98.

    8. Google Scholar

  8. George JN, Nester CM. Syndromes of thrombotic microangiopathy. New England J Med. 2014;371(7):654-66.

    9. Indexed at, Google Scholar, Cross Ref

  9. Cuker A, Cines DB. Immune thrombocytopenia. Hematology 2010, the American Society of Hematology Education Program Book. 2010;2010(1):377-84.

    10. Indexed at, Google Scholar

  10. Neunert C,. American Society of Hematology 2019 guidelines for immune thrombocytopenia. Blood advances. 2019 Dec 10;3(23):3829-66.

    11. Indexed at, Google Scholar, Cross Ref

Get the App